Charles Schwab Investment Management Inc Elevation Oncology, Inc. Transaction History
Charles Schwab Investment Management Inc
- $521 Billion
- Q1 2025
A detailed history of Charles Schwab Investment Management Inc transactions in Elevation Oncology, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 181,694 shares of ELEV stock, worth $54,508. This represents 0.0% of its overall portfolio holdings.
Number of Shares
181,694
Previous 124,181
46.31%
Holding current value
$54,508
Previous $72,000
34.72%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ELEV
# of Institutions
73Shares Held
33.2MCall Options Held
65KPut Options Held
4K-
Frazier Life Sciences Management, L.P. Menlo Park, CA5.99MShares$1.8 Million0.1% of portfolio
-
Bml Capital Management, LLC Zionsville, IN5.89MShares$1.77 Million1.24% of portfolio
-
Tang Capital Management LLC San Diego, CA4.76MShares$1.43 Million0.08% of portfolio
-
Aisling Capital Management LP New York, NY2.83MShares$850,4730.26% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.59MShares$775,5660.0% of portfolio
About Elevation Oncology, Inc.
- Ticker ELEV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 23,300,900
- Market Cap $6.99M
- Description
- Elevation Oncology, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for the treatment of cancer in genomically defined patient populations in the United States. The company's lead program is the seribantumab, an anti-HER3 monoclonal antibody that is in Phase II CRESTONE trial for the treatment of advanced sol...